About: State-of-the-Art Review: Hypertension Practice Guidelines in the Era of COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: State-of-the-Art Review: Hypertension Practice Guidelines in the Era of COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	State-of-the-Art Review: Hypertension Practice Guidelines in the Era of COVID-19
Creator	Vo, Thanh Deming, John Ferdinand, Keith Echols, Melvin Fnla,
source	Elsevier; Medline; PMC
abstract	The global burden of hypertension (HTN) is immense and increasing. In fact, HTN is the leading risk factor for adverse cardiovascular disease outcomes. Due to the critical significance and increasing prevalence of the disease, several national and international societies have recently updated their guidelines for the diagnosis and treatment of HTN. In consideration of the COVID-19 pandemic, this report provides clinicians with the best strategies to prevent HTN, manage the acute and long-term cardiac complications of HTN, and provide the best evidence-based care to patients in an ever-changing healthcare environment. The overarching goal of the various HTN guidelines is to provide easily accessible information to healthcare providers and public health officials, which is key for optimal clinical practice. However, the COVID-19 pandemic has challenged the ability to provide safe care to the most vulnerable hypertensive populations throughout the world. Therefore, this review compares the most recent guidelines of the 2017 American College of Cardiology/American Heart Association and multiple U.S. societies, the 2018 European Society of Cardiology/European Society of Hypertension, the 2019 National Institute for Care and Health Excellence, and the 2020 International Society of Hypertension. While a partial emphasis is placed on the management of HTN in the midst of COVID-19, this review will summarize current concepts and emerging data from the listed HTN guidelines on the diagnosis, monitoring, management, and evidence-based treatments in adults.
has issue date	2020-07-15(xsd:dateTime)
bibo:doi	10.1016/j.ajpc.2020.100038
bibo:pmid	32835351
has license	no-cc
sha1sum (hex)	febe2c0170c4b5a03fc91f369ae2e4d0b338fd50
schema:url	https://doi.org/10.1016/j.ajpc.2020.100038
resource representing a document's title	State-of-the-Art Review: Hypertension Practice Guidelines in the Era of COVID-19
has PubMed Central identifier	PMC7361040
has PubMed identifier	32835351
schema:publication	Am J Prev Cardiol
resource representing a document's body	covid:febe2c0170c4b5a03fc91f369ae2e4d0b338fd50#body_text
is schema:about of	named entity 'manage' named entity 'adults' named entity 'public health' named entity 'key' named entity 'healthcare' named entity 'pandemic' named entity 'Journal' named entity 'DIAGNOSIS' named entity 'PUBLIC HEALTH' named entity 'COVID-19 PANDEMIC' named entity 'TREATMENT' named entity 'DATA' named entity 'PATIENTS' named entity 'ACCESSIBLE' named entity 'MANAGE' named entity 'HYPERTENSION' named entity 'UPDATED' named entity 'CURRENT' named entity 'HEALTHCARE' named entity 'REPORT' named entity 'management' named entity 'adverse' named entity 'environment' named entity 'risk factor' named entity 'global' named entity 'COVID-19' named entity 'current' named entity 'COVID-19' named entity 'public health' named entity 'cardiovascular disease' named entity 'Hypertension' named entity 'hypertension' named entity 'systolic' named entity 'Blood Pressure' named entity 'ABPM' named entity 'cardiovascular disease' named entity 'CVD' named entity 'antihypertensive' named entity 'IL-6' named entity 'CDC' named entity 'antihypertensive' named entity 'direct current' named entity 'home blood pressure monitoring' named entity 'home blood pressure monitoring' named entity 'CVD' named entity 'COVID-19' named entity 'long-term' named entity 'outpatient' named entity 'cardiovascular care' named entity 'mercury' named entity 'biochemical' named entity 'Dietary Approaches to Stop Hypertension' named entity 'ABPM' named entity 'Systolic Blood Pressure Intervention Trial' named entity 'polypharmacy' named entity 'mmHg' named entity 'Alabama' named entity 'medical care' named entity 'Medicare' named entity 'pneumocytes' named entity 'ARB' named entity 'deciliter' named entity 'major and minor differences' named entity 'AHA' named entity 'long-term' named entity 'meta-analysis' named entity 'NICE guidelines' named entity 'respiratory disease' named entity 'telehealth' named entity 'renin' named entity 'CVD' named entity 'Heart Failure Society of America' named entity 'controlled trials' named entity 'AHA' named entity 'telehealth' named entity 'hypertension' named entity 'telehealth'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software